APAC CIOOutlook

Advertise

with us

  • Technologies
      • Artificial Intelligence
      • Big Data
      • Blockchain
      • Cloud
      • Digital Transformation
      • Internet of Things
      • Low Code No Code
      • MarTech
      • Mobile Application
      • Security
      • Software Testing
      • Wireless
  • Industries
      • E-Commerce
      • Education
      • Logistics
      • Retail
      • Supply Chain
      • Travel and Hospitality
  • Platforms
      • Microsoft
      • Salesforce
      • SAP
  • Solutions
      • Business Intelligence
      • Cognitive
      • Contact Center
      • CRM
      • Cyber Security
      • Data Center
      • Gamification
      • Procurement
      • Smart City
      • Workflow
  • Home
  • CXO Insights
  • CIO Views
  • Vendors
  • News
  • Conferences
  • Whitepapers
  • Newsletter
  • Awards
Apac
  • Artificial Intelligence

    Big Data

    Blockchain

    Cloud

    Digital Transformation

    Internet of Things

    Low Code No Code

    MarTech

    Mobile Application

    Security

    Software Testing

    Wireless

  • E-Commerce

    Education

    Logistics

    Retail

    Supply Chain

    Travel and Hospitality

  • Microsoft

    Salesforce

    SAP

  • Business Intelligence

    Cognitive

    Contact Center

    CRM

    Cyber Security

    Data Center

    Gamification

    Procurement

    Smart City

    Workflow

Menu
    • Cyber Security
    • Hotel Management
    • Workflow
    • E-Commerce
    • Business Intelligence
    • MORE
    #

    Apac CIOOutlook Weekly Brief

    ×

    Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Apac CIOOutlook

    Subscribe

    loading

    THANK YOU FOR SUBSCRIBING

    Terumo Acquires Quirem Medical

    Terumo Buys 80.1 percent of Quirem Medical’s shares to successfully acquire the company for enhancing the technology to treat unresectable liver cancer  

    Terumo Acquires Quirem Medical

    By

    Apac CIOOutlook | Friday, July 24, 2020

    Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.

    Terumo Buys 80.1 percent of Quirem Medical’s shares to successfully acquire the company for enhancing the technology to treat unresectable liver cancer

    Fremont, CA: Terumo Corporation announces the successful completion of the acquisition process of Quirem Medical B.V., a Netherlands-based healthcare startup whose specialties lie in the development of next-gen microspheres for Selective Internal Radiation Therapy (SIRT), a treatment designed for liver tumors. According to the terms of the agreement, Terumo acquired 80.1 percent of the shares of Quirem Medical. This is higher than its current share position of 19.9 percent, making Quirem Medical now a wholly-owned subsidiary of Terumo.

    Terumo has agreed to make a one-time, up-front payment of USD 20 million with up to USD 25 million in additional payments depending on the achievements of Quirem Medical by 2030. The transaction will be funded via cash on hand and will not significantly impact the company’s financial projections for the current fiscal year untill March 31, 2021.

    Quirem Medical has focussed its resources on developing and manufacturing the QuiremSpheres, the only commercially available microspheres that contain the radioactive isotope Holmium-166. Recently conducted trials have displayed the safety and efficacy of these Holmium microspheres for unresectable liver cancer treatment. For improving the process of patient selection, therapy planning and procedure verification, QuiremSpheres can be utilized to visualize and quantify even the lowest concentrations using Single-Photon Emission Computed Tomography (SPECT) and Magnetic Resonance Imaging (MRI). This is unique and cannot be carried out with the currently available Yttrium-90 based microspheres.

    “The acquisition of Quirem Medical further strengthens our business, expands on our manufacturing and clinical development activities, and complements our comprehensive suite of offerings to support our customers,” said Jim Rushworth, Chief Commercial Officer of the Interventional Systems Division of Terumo.
    “We are very excited with the acquisition of Quirem Medical by Terumo as it will further drive the adoption of our unique product offerings worldwide and accelerate our pace of innovation, reaching more patients that will benefit from our technology,” said Jan Sigger, CEO of Quirem Medical.

    Terumo has been aggregating its presence in the interventional oncology field, with offerings such as the microcatheter system (Progreat), compressible microspheres for embolization (HydroPearl), drug-eluting microspheres (LifePearl), and biodegradable drug-eluting microspheres (BioPearl). In 2015, Terumo invested in Quirem Medical to become the exclusive global distributor of their technology.

    More in News

    The Journey Towards Smart City Development

    The Journey Towards Smart City Development

    Harnessing Big Data Analytics to Enhance Business Strategies

    Harnessing Big Data Analytics to Enhance Business Strategies

    AI's Role in Apac's Digital Transformation Journey

    AI's Role in Apac's Digital Transformation Journey

    Impact of Digital Transformation on Retail

    Impact of Digital Transformation on Retail

    I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

    Copyright © 2025 APAC CIOOutlook. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Use and Privacy and Anti Spam Policy 

    Home |  CXO Insights |   Whitepapers |   Subscribe |   Conferences |   Sitemaps |   About us |   Advertise with us |   Editorial Policy |   Feedback Policy |  

    follow on linkedinfollow on twitter follow on rss
    This content is copyright protected

    However, if you would like to share the information in this article, you may use the link below:

    https://www.apacciooutlook.com/news/terumo-acquires-quirem-medical-nwid-7621.html